Physician

Rachel Kim

According to 2025 Medicare claims, Rachel Kim (NPI: 1326496563) practices thoracic surgery in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is ASPIRUS MEDICAL GROUP, INC. (NPI: 1235421918; TIN: 391670223) and primary practice location at 54401-4120. Kim is affiliated with the IRCCO (ACO ID: A2619) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 137 traditional Medicare patients, billed 271 HCPCS/CPT codes, and received $100,056 in Medicare payments. The top billing code was 33361 (Replacement of aortic valve through the skin and femoral artery). Part D data shows 96 prescription claims across 33 beneficiaries totaling $3,043 in drug costs, led by Metoprolol Tartrate (Metoprolol Tartrate). DME data shows 11 claims. Open Payments data shows 3 records totaling $526. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,026 to $3,043. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$50K$100K2023 Medicare payment: $13,036 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $100,056 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20233863$13,036
2024137271$100,056

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.7K$5.5K2016 Drug cost: $1,026 (USD; Tot_Drug_Cst)2017 Drug cost: $5,464 (USD; Tot_Drug_Cst)2018 Drug cost: $1,834 (USD; Tot_Drug_Cst)2019 Drug cost: $1,741 (USD; Tot_Drug_Cst)2021 Drug cost: $215 (USD; Tot_Drug_Cst)2024 Drug cost: $3,043 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161229$1,026
20172667$5,464
20181142$1,834
2019N/R47$1,741
2020N/RN/RN/R
2021N/R12$215
2022N/RN/RN/R
2023N/RN/RN/R
20243396$3,043

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$464$9272024 Medicare payment: $927 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R11$927

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
33361Replacement of aortic valve through the skin and femoral artery3333$597
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more4949$158
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3737$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2527$98
33508Harvest of vein using an endoscope1919$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Metoprolol TartrateMetoprolol Tartrate311,590$103

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R11$927

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$526ABIOMED
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rachel Kim?

Tedicare shows public-source Medicare data for Rachel Kim (NPI 1326496563), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Kim have ACO affiliation data?

Rachel Kim is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Rachel Kim?

Rachel Kim is linked to ASPIRUS MEDICAL GROUP, INC. (billing NPI 1235421918) in the available physician profile data.

Does Rachel Kim have Open Payments data?

Rachel Kim has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.